The Oncosearch | Oncotarget

Triple-negative breast cancer: is there a treatment on the horizon? Review

Hui Yao, Guangchun He, Shichao Yan, Chao Chen, Liujiang Song, Thomas J. Rosol, Xiyun Deng

Published Sep 27, 2016 · Vol. 8, No. 1 · pp. 1913-1924

Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells Research Paper

Weina Zhang, Lechuang Chen, Kai Ma, Yahui Zhao, Xianghe Liu, Yu Wang, Mei Liu, Shufang Liang, Hongxia Zhu, Ningzhi Xu

Published Sep 23, 2016 · Vol. 7, No. 46 · pp. 75366-75378

Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab Research Paper

Aidong Wang, Ming Cui, Hong Qu, Jiabo Di, Zaozao Wang, Jiadi Xing, Fan Wu, Wei Wu, Xicheng Wang, Lin Shen, Beihai Jiang, Xiangqian Su

Published Sep 21, 2016 · Vol. 7, No. 46 · pp. 75293-75306

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation Research Paper

Yan Li, Yanmei Wang, Kai Niu, Xiewan Chen, Liqin Xia, Dingxi Lu, Rui Kong, Zhengtang Chen, Yuzhong Duan, Jianguo Sun

Published Sep 16, 2016 · Vol. 7, No. 43 · pp. 70535-70545

SMAD4 loss enables EGF, TGFÎ²1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells Research Paper

Stefania Moz, Daniela Basso, Dania Bozzato, Paola Galozzi, Filippo Navaglia, Ola H. Negm, Giorgio Arrigoni, Carlo-Federico Zambon, Andrea Padoan, Paddy Tighe, Ian Todd, Cinzia Franchin, Sergio Pedrazzoli, Leonardo Punzi, Mario Plebani

Published Sep 16, 2016 · Vol. 7, No. 43 · pp. 69927-69944

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer Research Paper

Li Wang, Haifeng Li, Shiping Yang, Wenqiang Ma, Mei Liu, Shichao Guo, Jun Zhan, Hongquan Zhang, Suk Ying Tsang, Ziding Zhang, Zhaoyi Wang, Xiru Li, Yang-Dong Guo, Xiangdong Li

Published Sep 15, 2016 · Vol. 7, No. 42 · pp. 68864-68882

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer Research Paper

Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Yves-Jean Bignon, FrÃ©dÃ©rique Penault-Llorca, Corinne Aubel

Published Sep 15, 2016 · Vol. 7, No. 45 · pp. 73618-73637

Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype Clinical Research Papers

Qi Wu, Juanjuan Li, Shan Zhu, Juan Wu, Xiang Li, Qian Liu, Wen Wei, Shengrong Sun

Published Sep 15, 2016 · Vol. 7, No. 52 · pp. 87532-87542

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma Clinical Research Papers

Xiaoyan Ma, Hui Zhu, Hongbo Guo, Anqin Han, Haiyong Wang, Wang Jing, Yan Zhang, Li Kong, Jinming Yu

Published Sep 8, 2016 · Vol. 7, No. 49 · pp. 81906-81917

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer Research Paper

Nathan Bucay, Kirandeep Sekhon, Shahana Majid, Soichiro Yamamura, Varahram Shahryari, Z. Laura Tabatabai, Kirsten Greene, Yuichiro Tanaka, Rajvir Dahiya, Guoren Deng, Sharanjot Saini

Published Sep 6, 2016 · Vol. 7, No. 43 · pp. 70388-70403

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer ⁸⁹Zr-imgatuzumab Research Paper

Martin Pool, Arjan Kol, Marjolijn N. Lub-de Hooge, Christian A. Gerdes, Steven de Jong, Elisabeth G.E. de Vries, Anton G.T. Terwisscha van Scheltinga

Published Sep 2, 2016 · Vol. 7, No. 42 · pp. 68111-68121

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer Research Paper

Chih-Ming Su, Ting-Yu Chang, Hui-Ping Hsu, Hui-Huang Lai, Jie-Ning Li, Yu-Jhen Lyu, Kuang-Tai Kuo, Ming-Te Huang, Jen-Liang Su, Pai-Sheng Chen

Published Aug 31, 2016 · Vol. 7, No. 39 · pp. 63924-63936

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion Research Paper

Yan Fang, Jiayi Wu, Wei Wang, Xiaochun Fei, Yu Zong, Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, Li Zhu

Published Aug 26, 2016 · Vol. 7, No. 39 · pp. 64182-64190

Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells Research Paper

Mohit P. Mathew, Elaine Tan, Christopher T. Saeui, Patawut Bovonratwet, Samuel Sklar, Rahul Bhattacharya, Kevin J. Yarema

Published Aug 24, 2016 · Vol. 7, No. 41 · pp. 66491-66511

Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells Research Paper

Raghuveer Kavarthapu, Maria L. Dufau

Published Aug 24, 2016 · Vol. 7, No. 40 · pp. 65602-65613

Integrin Î²1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer Research Paper

Cheolwon Choi, Junyeob Kwon, Sunyoung Lim, David M. Helfman

Published Aug 23, 2016 · Vol. 7, No. 39 · pp. 63466-63487

Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells Research Paper

Wei-Chien Huang, Chao-Ming Hung, Ching-Ting Wei, Tsung-Ming Chen, Pei-Hsuan Chien, Hsiao-Lin Pan, Yueh-Ming Lin, Yun-Ju Chen

Published Aug 22, 2016 · Vol. 7, No. 38 · pp. 62352-62363

Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling Research Paper

Bao-Qing Xu, Zhi-Guang Fu, Yao Meng, Xiao-Qing Wu, Bo Wu, Liang Xu, Jian-Li Jiang, Ling Li, Zhi-Nan Chen

Published Aug 19, 2016 · Vol. 7, No. 38 · pp. 62177-62193

Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009 Clinical Research Papers

Zuxiang Peng, Jia Wei, Xuesong Lu, Hong Zheng, Xiaorong Zhong, Weiguo Gao, Yunqin Chen, Jing Jing

Published Aug 18, 2016 · Vol. 7, No. 47 · pp. 78168-78179

Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration Priority Research Paper

Erin Greenwood, Sabrina Maisel, David Ebertz, Atlantis Russ, Ritu Pandey, Joyce Schroeder

Published Aug 17, 2016 · Vol. 7, No. 38 · pp. 60776-60792

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Triple-negative breast cancer: is there a treatment on the horizon? Review

Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells Research Paper

Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab Research Paper

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation Research Paper

SMAD4 loss enables EGF, TGFÎ²1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells Research Paper

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer Research Paper

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer Research Paper

Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype Clinical Research Papers

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma Clinical Research Papers

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer Research Paper

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer ⁸⁹Zr-imgatuzumab Research Paper

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer Research Paper

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion Research Paper

Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells Research Paper

Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells Research Paper

Integrin Î²1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer Research Paper

Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells Research Paper

Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling Research Paper

Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009 Clinical Research Papers

Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Triple-negative breast cancer: is there a treatment on the horizon? Review

Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells Research Paper

Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab Research Paper

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation Research Paper

SMAD4 loss enables EGF, TGFÎ²1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells Research Paper

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer Research Paper

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer Research Paper

Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype Clinical Research Papers

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma Clinical Research Papers

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer Research Paper

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab Research Paper

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer Research Paper

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion Research Paper

Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells Research Paper

Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells Research Paper

Integrin Î²1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer Research Paper

Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells Research Paper

Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling Research Paper

Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009 Clinical Research Papers

Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration Priority Research Paper

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer ⁸⁹Zr-imgatuzumab Research Paper